Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (251-260 of 337) with videos related to

Pageof 34
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|July 11, 2013
[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine]Jenneke Boot, Babette O Rump, Charles A B Boucher, et al.
Drug Safety|January 14, 2018
Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver CirrhosisRianne A Weersink, Margriet Bouma, David M Burger, et al.
The Pediatric Infectious Disease Journal|February 24, 2018
Pharmacokinetics, Short-term Safety and Efficacy of the Approved Once-daily Darunavir/Ritonavir Dosing Regimen in HIV-infected ChildrenDiane E T Bastiaans, Sibyl P M Geelen, Eline G Visser, et al.
British Journal of Clinical Pharmacology|May 14, 2017
Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanibNienke A G Lankheet, Ingrid M E Desar, Sasja F Mulder, et al.
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|April 21, 2023
Exploring the Breastfeeding Desires and Decision-Making of Women Living with HIV in the Netherlands: Implications for Perinatal HIV Management in Developed CountriesVera E Bukkems, Renee N N Finkenflügel, Karin Grintjes, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2005
Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patientsReshma Saskia Autar, Marta Boffito, Elly Hassink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2023
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 TrialLisanne A H Bevers, Hylke Waalewijn, Alexander J Szubert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2019
Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese IndividualsRoeland E Wasmann, Cornelis Smit, Eric P H van Dongen, et al.
AIDS (London, England)|April 11, 2006
The genotypic inhibitory quotient and the (cumulative) number of mutations predict the response to lopinavir therapyJolanda G M Hoefnagel, Manon J van der Lee, Peter P Koopmans, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2020
Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink DosingEline W Muilwijk, Dylan W de Lange, Jeroen A Schouten, et al.
Pageof 34

Showing results (251-260 of 337) with videos related to

Sort By:
Pageof 34
Nederlands Tijdschrift Voor Geneeskunde|July 11, 2013
[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine]Jenneke Boot, Babette O Rump, Charles A B Boucher, et al.
Drug Safety|January 14, 2018
Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver CirrhosisRianne A Weersink, Margriet Bouma, David M Burger, et al.
The Pediatric Infectious Disease Journal|February 24, 2018
Pharmacokinetics, Short-term Safety and Efficacy of the Approved Once-daily Darunavir/Ritonavir Dosing Regimen in HIV-infected ChildrenDiane E T Bastiaans, Sibyl P M Geelen, Eline G Visser, et al.
British Journal of Clinical Pharmacology|May 14, 2017
Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanibNienke A G Lankheet, Ingrid M E Desar, Sasja F Mulder, et al.
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|April 21, 2023
Exploring the Breastfeeding Desires and Decision-Making of Women Living with HIV in the Netherlands: Implications for Perinatal HIV Management in Developed CountriesVera E Bukkems, Renee N N Finkenflügel, Karin Grintjes, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2005
Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patientsReshma Saskia Autar, Marta Boffito, Elly Hassink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2023
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 TrialLisanne A H Bevers, Hylke Waalewijn, Alexander J Szubert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2019
Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese IndividualsRoeland E Wasmann, Cornelis Smit, Eric P H van Dongen, et al.
AIDS (London, England)|April 11, 2006
The genotypic inhibitory quotient and the (cumulative) number of mutations predict the response to lopinavir therapyJolanda G M Hoefnagel, Manon J van der Lee, Peter P Koopmans, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2020
Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink DosingEline W Muilwijk, Dylan W de Lange, Jeroen A Schouten, et al.
Pageof 34